CRT 2026
Coronary
Shrilla Banerjee, MD, FRCP, FESC
Consultant Interventional Cardiologist
Surrey and Sussex Healthcare NHS Trust
Redhill, England, United Kingdom
Disclosure(s): General Electric: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, September 10, 2025)
Nathaniel R. Smilowitz, MD
Assistant Professor of Medicine
NYU Langone Health
New York, New York, United States
Disclosure(s): Abbott Vascular,: Consulting Fees (e.g., advisory boards) (Ongoing); AngioInsight: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing)
Pieter C. Smits, PhD, FESC
Chief Medical Director
CERC (Cardiovascular European Research Center)
Rotterdam, Zuid-Holland, Netherlands
Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Terminated, October 1, 2025), Grant/Research Support (Terminated, October 1, 2025); CERC ( centre european of cardiovascular research): Employee (Ongoing), Stock-privately held company (Ongoing); MicroPort Medical: Consulting Fees (e.g., advisory boards) (Ongoing); SMT: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, October 1, 2025)